HALLURA

About

HALLURA is an aesthetic medical company focused on developing innovative hyaluronic acid (HA) dermal fillers. Founded by a team of experts, including Stéphane Meunier, Ph.D., the company aims to enhance safety and efficacy in the aesthetic industry. Their flagship technology, the BiOLinkMatrix platform, utilizes advanced methods inspired by the 2022 Nobel Prize in Chemistry. This proprietary platform allows for a BDDE-free formulation that maintains the integrity of HA polymer chains, resulting in fillers that integrate better with tissue and minimize side reactions. HALLURA's products are designed for healthcare professionals and include treatments that stimulate collagen production, smooth lines, restore volume, and promote skin lifting and regeneration. HALLURA's commitment to safety and effectiveness is demonstrated through pre-clinical and clinical trials in Europe, showcasing excellent outcomes. The company aims to set new benchmarks in the industry and expand its global reach by achieving regulatory approvals for its innovative technology.